Advisor Group’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$487K Buy
8,830
+789
+10% +$42.8K ﹤0.01% 1688
2019
Q3
$406K Buy
8,041
+1,045
+15% +$52.5K ﹤0.01% 1763
2019
Q2
$353K Sell
6,996
-384
-5% -$18.6K ﹤0.01% 1863
2019
Q1
$344K Sell
7,380
-2,583
-26% -$131K ﹤0.01% 1862
2018
Q4
$489K Buy
9,963
+4,022
+68% +$229K ﹤0.01% 1416
2018
Q3
$368K Buy
5,941
+1,313
+28% +$79.8K ﹤0.01% 1698
2018
Q2
$249K Sell
4,628
-306
-6% -$15.3K ﹤0.01% 1812
2018
Q1
$224K Buy
4,934
+242
+5% +$10.4K ﹤0.01% 1886
2017
Q4
$184K Buy
4,692
+178
+4% +$6.77K ﹤0.01% 2062
2017
Q3
$166K Buy
4,514
+627
+16% +$22.3K ﹤0.01% 1991
2017
Q2
$150K Buy
3,887
+982
+34% +$36K ﹤0.01% 1988
2017
Q1
$99K Buy
2,905
+578
+25% +$19K ﹤0.01% 2154
2016
Q4
$76K Sell
2,327
-128
-5% -$4.15K ﹤0.01% 2259
2016
Q3
$80K Buy
2,455
+478
+24% +$15.5K ﹤0.01% 2157
2016
Q2
$60K Buy
+1,977
New +$61.8K ﹤0.01% 2279

Other funds holding EHC

Advisor Group's EHC Position: Q4 2019 in Review

Advisor Group increased its Encompass Health (EHC) stake by 9.8% in Q4 2019, buying an estimated $42.8K and bringing the position to 8,830 shares worth $487K. The position accounts for ﹤0.01% of the portfolio, ranked #1688.

Advisor Group first reported a position in EHC in Q2 2016 and has held it in 15 quarters since. The position peaked at $489K in Q4 2018. 397 funds tracked by Wall St. Rank hold EHC as of Q4 2019.

  • Advisor Group held 8,830 shares of Encompass Health worth $487K as of Q4 2019.
  • Advisor Group bought 789 Encompass Health shares in Q4 2019, an estimated $42.8K.
  • Encompass Health made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #1688 holding.
  • Advisor Group first reported a position in Encompass Health in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Encompass Health position peaked at $489K in Q4 2018.
  • 397 funds tracked by Wall St. Rank held Encompass Health as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.